Pancreatic Cancer Research

ResearcherSeoul National UniversityActive in the last 2 years

Tae Seung Lee

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0007-0714-7653; OpenAlex author ID A5110066814, A5127848828. Sources: OpenAlex.

Their work

Papers
5 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2024: 1 paper · 2025: 2 papers · 2026: 2 papers

Papers 5

  1. Lorazepam and Survival in Asian Patients with Pancreatic Cancer: A Retrospective Cohort Study. Co-author DOI 10.1007/s12029-026-01429-7↗
  2. Treatment Outcomes in Frail Patients with Advanced Pancreatic Ductal Adenocarcinoma: A Real-World Comparison of Gemcitabine, S-1, and Stereotactic Ablative Rad… Co-author DOI 10.1159/000552276↗
  3. Are Probiotics Beneficial or Harmful for Pancreatic Cancer Outcomes? Co-author DOI 10.1007/s12602-024-10437-7↗
  4. Metronidazole Exposure Has Limited Impact on Clinical Outcomes in Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000002499↗
  5. Pancreatic Cancer Treatment Targeting the HGF/c-MET Pathway: The MEK Inhibitor Trametinib. First author DOI 10.3390/cancers16051056↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Woo Hyun Paik · 4 shared papers, 2024–2026 · strength 1.15
  2. In Rae Cho · 3 shared papers, 2024–2026 · strength 0.85
  3. Ji Kon Ryu · 3 shared papers, 2024–2026 · strength 0.85
  4. Jin Ho Choi MD · 2 shared papers, 2026 · strength 0.62
  5. Sang Hyub Lee · 2 shared papers, 2024–2026 · strength 0.56
  6. Chang Hyun Kim · 1 shared paper, 2026 · strength 0.29
  7. Eui Kyu Chie · 1 shared paper, 2026 · strength 0.29
  8. Junyeol Kim · 1 shared paper, 2024 · strength 0.23
  9. Yong‐Tae Kim · 1 shared paper, 2024 · strength 0.23

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.